Cargando…
Cystatin C and Risk of Diabetes and the Metabolic Syndrome – Biomarker and Genotype Association Analyses
BACKGROUND: We recently reported a relationship between plasma levels of cystatin C and incidence of the metabolic syndrome (MetS) among the first 2,369 subjects who participated in the re-examination study of the population-based Malmö and Diet Cancer Cardiovascular cohort (MDC-CC-re-exam). In this...
Autores principales: | Magnusson, Martin, Molvin, John, Engström, Gunnar, Svensson-Färbom, Patrik, Persson, Margaretha, Christensson, Anders, Nilsson, Peter, Melander, Olle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878806/ https://www.ncbi.nlm.nih.gov/pubmed/27218257 http://dx.doi.org/10.1371/journal.pone.0155735 |
Ejemplares similares
-
Cystatin C Is Not Causally Related to Coronary Artery Disease
por: Svensson-Färbom, Patrik, et al.
Publicado: (2015) -
Atrial Natriuretic Peptide and Type 2 Diabetes Development – Biomarker and Genotype Association Study
por: Jujić, Amra, et al.
Publicado: (2014) -
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study
por: Schulz, Christina-Alexandra, et al.
Publicado: (2016) -
Genetic Predisposition for Renal Dysfunction and Incidence of CKD in the Malmö Diet and Cancer Study
por: Schulz, Christina-Alexandra, et al.
Publicado: (2019) -
Genetic determinants of growth hormone and GH-related phenotypes
por: Hallengren, Erik, et al.
Publicado: (2017)